Alzheimer's Disease Trial, Recruiting NCT06104852 Sponsor: Adams Clinical Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06104852
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed the study's consent form before any study-related procedures begin (and their study partner, if one is required, must also sign).
  • People who are at least 18 years old (and their study partner, if one is required, must also be at least 18).

Who may not be able to join:

  • People who do not have the language skills or thinking ability needed to understand the screening process.
  • People who are pregnant, breastfeeding, or planning to become pregnant.
  • People with a history of a significant illness that the study doctor believes could affect safety or make it harder to analyse the study results.
  • People who are considered to be at serious and immediate risk of suicide, based on specific responses given on a standard suicide risk assessment tool used during screening.
  • People who have had a moderate or severe problem with substance use in the 90 days before screening, if the study doctor believes this could pose too great a risk.
  • People with any other condition that the study doctor believes makes them unsuitable for the study (confirm with trial site).
  • People who are currently employed by Adams Clinical, or who are a close family member (parent, child, or sibling) of someone working on this study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 6177448542

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Adams Clinical
Registry
ClinicalTrials.gov
Start date
2 June 2023
Est. completion
2 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of the clinical trial seeking population for whom industry-sponsored clinical research is clinically appropriate, as defined as those who go on to screen for a study.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov